Resonant Medical to Exhibit Next Generation Clarity System at Europe`s Pre-Eminent Radiation Oncology Conference

MAASTRO Clinic introduces Clarity System, available throughout Europe for
guidance, planning and adaptive radiotherapy in soft tissue cancers, for first
time in the Netherlands
MONTREAL--(Business Wire)--
Resonant Medical, an innovator in soft tissue planning, image-guidance and
adaptive radiotherapy products, today announced that the Company will be
exhibiting the next generation of its multi-anatomy Clarity System at the 10th
Biennial Meeting of The European Society of Therapeutic Radiology and
Oncologists (ESTRO), being held in Maastricht, Netherlands.

Clarity provides cost effective soft tissue hybrid imaging, integrated within a
singular point-of-care in the CT Suite. Clarity also provides structure based
image-guided radiotherapy (IGRT) during daily radiation treatments. The next
generation version of Clarity also supports adaptive radiotherapy by alerting
physicians of changes in a target structure`s precise location, shape and size
and enabling them to use this information to adapt the patient`s treatment plan
as necessary. Additionally, the MAASTRO Clinic in Maastricht has begun offering
the Clarity System for its prostate and breast treatments.

"We are honoured that the prestigious MAASTRO Clinic has adopted the Clarity
System for clinical use in advanced planning and soft tissue based IGRT, thus
expanding the availability of better patient care in Europe," said Tony Falco,
founder and CEO of Resonant Medical. "Our continued momentum in the European
market is further evidence that the radiation oncology community is recognizing
the need to address the issue of tumor movement in soft tissue cancers, like
breast cancer. As we unveil the latest generation of Clarity products at ESTRO,
we hope to make the Clarity System available to an increasing number of cancer
patients in Europe."

During the radiation treatment planning phase, Clarity allows physicians to
automatically compare CT and 3D ultrasound images acquired at the same time with
the patient in the same position, which can dramatically improve the treatment
planning workflow when compared to CT alone. The Clarity System is based on
daily auto-contouring and true 3D anatomy changes during the entire course of
treatment, ensuring rapid and precise daily delivery to the intended target
while sparing healthy tissue. Clarity`s 3D ultrasound imaging is a gentle,
non-invasive technology most often associated with pregnancy and providing
images of babies. In addition to adding the Clarity System to treatment for
breast and prostate cancer patients, physicians at MAASTRO will be exploring how
the system may improve treatment planning and targeting in GYN, bladder and
liver cancer patients.

"The MAASTRO Clinic is excited to offer this new application of 3D ultrasound
technology that advances patient care by providing more accurate planning and
guidance in the delivery of treatment to patients battling breast and prostate
cancer," said Dr. Frank Verhaegen, Head of Physics at MAASTRO."The Clarity
System is radiation-free and with the information it provides physicians,
patients can rest easier knowing that their radiation treatment can be delivered
directly to the area where it is needed most. We are also excited about possible
future collaborations with Resonant to develop additional applications of the
Clarity System to continue addressing the issue of tumor movement in soft tissue
cancers."

About the MAASTRO Clinic

MAASTRO Clinic (Maastricht Radiation Oncology Clinic; www.maastro.nl) is a
dedicated radiotherapy clinic, which has strategic agreements with the GROW
research institute (School for Developmental Biology and Oncology;
www.grow-um.nl), the Faculty of Health, Medicine and Life Sciences at Maastricht
University and the University Hospital of Maastricht. MAASTRO Clinic offers
state-of-the-art radiotherapy to more than 3500 cancer patients each year from
the Limburg area in the Netherlands. One of the missions of MAASTRO Clinic is
implementing and developing advanced imaging techniques for image-guided
radiotherapy.

For further information visit: www.maastro.nl.

About Resonant Medical

Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D
ultrasound planning, image-guidance, and adaptive radiotherapy products.
Resonant`s technologies are available in cancer centers throughout the U.S.,
Canada and Europe, helping cancer centers make significant improvements in
patient care.

For further information visit: www.resonantmedical.com.

Schwartz Communications
Caitlin Hunt/Colleen Connolly, 781-684-0770
resonant@schwartz-pr.com

Copyright Business Wire 2009